Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Medtronic
Boehringer Ingelheim
Healthtrust
Citi
Queensland Health
McKesson
US Department of Justice
Fish and Richardson

Generated: July 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019437

« Back to Dashboard

NDA 019437 describes AMINOSYN II 8.5% W/ELECTROLYTES, which is a drug marketed by Icu Medical Inc and is included in one NDA. It is available from one supplier. Additional details are available on the AMINOSYN II 8.5% W/ELECTROLYTES profile page.

The generic ingredient in AMINOSYN II 8.5% W/ELECTROLYTES is amino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic. There are three hundred and forty-six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic profile page.
Suppliers and Packaging for NDA: 019437
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMINOSYN II 10% W/ ELECTROLYTES amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride INJECTABLE;INJECTION 019437 NDA Hospira, Inc. 0409-4171 N 0409-4171-03
AMINOSYN II 3.5% M amino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate INJECTABLE;INJECTION 019437 NDA Hospira, Inc. 0409-4171 N 0409-4171-03

Profile for product number 004

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100ML
Approval Date:Apr 3, 1986TE:RLD:No

Profile for product number 005

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100ML
Approval Date:Apr 3, 1986TE:RLD:No

Profile for product number 006

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100ML
Approval Date:Apr 3, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
Mallinckrodt
UBS
Farmers Insurance
Cipla
Merck
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.